US Map / Virginia
State VA

Clinical Trials in Virginia

Virginia is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Virginia and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 276 actively recruiting studies with Virginia sites out of 276 registered in total. The busiest research areas in Virginia are Breast Cancer, Advanced Solid Tumor, Colorectal Cancer. Leading sponsors running trials in the state include Virginia Commonwealth University, University of Virginia, National Cancer Institute (NCI). By stage, Virginia trials break down as Phase 1 (75), Phase 2 (82), Phase 3 (85), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
276
Recruiting Now
276
← Back to US Map
Top Conditions in Virginia
Breast Cancer (12)Advanced Solid Tumor (9)Colorectal Cancer (8)Solid Tumor (8)Prostate Cancer (8)Advanced Solid Tumors (7)Solid Tumors (6)Cancer (5)Ovarian Cancer (5)Obesity (5)Endometrial Cancer (4)Non-Small Cell Lung Cancer (4)

Frequently Asked Questions — Clinical Trials in Virginia

How many clinical trials are currently recruiting in Virginia?
ClinicalMetric currently tracks 276 actively recruiting clinical trials with at least one location in Virginia. The total number of registered studies—including active but not currently enrolling trials—is 276. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Virginia?
Virginia hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Colorectal Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Virginia serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Virginia?
To join a clinical trial in Virginia, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Virginia maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Virginia

NCT07224425 Phase 1
Recruiting
A Study of BI 3810944 in Patients With Advanced Cancer
Condition
Solid Tumours
Enrollment
69 pts
Location
United States, Belgium, Netherlands
Sponsor
Boehringer Ingelheim
View Trial →
NCT07227025 Phase 1, Phase 2
Recruiting
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With M...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
60 pts
Location
United States, Canada, China
Sponsor
Janssen Research & Development
View Trial →
NCT05107674 Phase 1
Recruiting
A Study of NX-1607 in Adults With Advanced Malignancies
Condition
Ovarian Cancer, Epithelial
Enrollment
345 pts
Location
United States, United Kingdom
Sponsor
Nurix Therapeutics, Inc.
View Trial →
NCT06966388 Phase 1
Recruiting
Study to Evaluate the Feasibility of Twice Daily Use of Topical Azelaic Acid in ...
Condition
Breast Cancer
Enrollment
33 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
View Trial →
NCT05240924 N/A
Recruiting
ERP to Improve Functioning in Veterans With OCD
Condition
Obsessive Compulsive Disorder (OCD)
Enrollment
160 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT03945162 Phase 2
Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Mus...
Condition
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Enrollment
90 pts
Location
United States, Canada
Sponsor
Theralase® Technologies Inc.
View Trial →
NCT07441889 Phase 1, Phase 2
Recruiting
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Condition
Breast Cancer
Enrollment
23 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
NCT06816992 Phase 1
Recruiting
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon...
Condition
Solid Tumors
Enrollment
76 pts
Location
United States, Australia, Canada
Sponsor
ORIC Pharmaceuticals
View Trial →
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Pa...
Condition
Ovarian Cancer
Enrollment
334 pts
Location
United States, Belgium, Germany
Sponsor
Gilead Sciences
View Trial →
NCT06492122 Phase 1
Recruiting
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
50 pts
Location
United States, Australia, China
Sponsor
Full-Life Technologies UK Limi
View Trial →
NCT06022029 Phase 1
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in ...
Condition
Triple Negative Breast Cancer
Enrollment
168 pts
Location
United States, Australia
Sponsor
OncoNano Medicine, Inc.
View Trial →
NCT07186101 Phase 2
Recruiting
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately ...
Condition
Ulcerative Colitis
Enrollment
252 pts
Location
United States, Austria, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT07007312 Phase 3
Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With...
Condition
Acute Myeloid Leukemia (AML)
Enrollment
1,300 pts
Location
United States, Australia, Belgium
Sponsor
Kura Oncology, Inc.
View Trial →
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
View Trial →
NCT05421741 Phase 4
Recruiting
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Condition
Osteomyelitis Tibia
Enrollment
242 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT04503395 N/A
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
Condition
Aortic Aneurysm, Abdominal
Enrollment
204 pts
Location
United States, Austria, Belgium
Sponsor
FCRE (Foundation for Cardiovas
View Trial →
NCT07128303 Phase 1
Recruiting
Study of GS-5319 Given Alone or in Combination in Adults With Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
476 pts
Location
United States, South Korea, Spain
Sponsor
Gilead Sciences
View Trial →
NCT05882058 Phase 2
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With...
Condition
Small Cell Lung Carcinoma
Enrollment
204 pts
Location
United States, Belgium, Bulgaria
Sponsor
Boehringer Ingelheim
View Trial →
NCT05826535 Phase 1, Phase 2
Recruiting
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Condition
Relapsed Non-Hodgkin Lymphoma
Enrollment
270 pts
Location
United States, Australia
Sponsor
Lyell Immunopharma, Inc.
View Trial →
NCT05732103 Phase 1, Phase 2
Recruiting
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk...
Condition
Acute Myeloid Leukemia
Enrollment
225 pts
Location
United States
Sponsor
Chordia Therapeutics, Inc.
View Trial →
NCT06998524 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Typ...
Condition
Von Willebrand Disease, Type 3
Enrollment
75 pts
Location
United States, Belgium, Canada
Sponsor
Hoffmann-La Roche
View Trial →
NCT05625659 N/A
Recruiting
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breas...
Condition
Breast Cancer
Enrollment
2,032 pts
Location
United States, Canada
Sponsor
American College of Radiology
View Trial →
Page 2 of 12 — 276 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology